These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 28902136)

  • 41. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
    Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
    Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer.
    Hamurcu Z; Sener EF; Taheri S; Nalbantoglu U; Kokcu ND; Tahtasakal R; Cınar V; Guler A; Ozkul Y; Dönmez-Altuntas H; Ozpolat B
    Cell Signal; 2021 Jul; 83():109979. PubMed ID: 33744419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [miR-342-3p Promotes the Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma Cells by Targeted Inhibition of PPM1E].
    Wang L; Li Z; Wu J; Xie J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):731-738. PubMed ID: 38948282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1.
    Zhao S; Wang Y; Lou Y; Wang Y; Sun J; Luo M; Li W; Miao L
    Oncol Rep; 2018 Oct; 40(4):1917-1926. PubMed ID: 30066895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
    Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
    Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
    Wang W; Guo Z; Yu H; Fan L
    J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
    Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
    Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
    Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
    Yamada Y; Arai T; Sugawara S; Okato A; Kato M; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Apr; 109(4):1239-1253. PubMed ID: 29417701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
    Wang X; Li H; Cui L; Feng J; Fan Q
    Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.